Proteomics International Laboratories (ASX:PIQ)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Proteomics International Laboratories.
RELATED STOCKHEAD STORIES
Health Check: All hail the hard-working bodily ‘spuds’ – it’s World Kidney Day
Health Check: Did the earth move for you? The world shifts on its axis as it enters the Trump era mark two
Tony’s Takeaway: New year nuggets for biotech-hungry investors
ASX Lunch Wrap: Stocks and Bitcoin drop as markets worry about US debt ceiling deadline
Health Check: Telix CEO gets pay bump as company files for US kidney imaging approval
Health Check: Latest biotech quarterly results are as patchy as the curate’s egg
Tony’s Takeaway: A second helping of biotech picks
Health Check: Proteomics reports ‘excellent’ results for blood-based esophageal cancer test
Alive and Kicking: Kidney diagnosis house Proteomics divorces its US partner
ASX Health Stocks: Proteomics to start selling in France; Recce to start clinical trials
Market Highlights: Nasdaq can’t stop rallying, but ‘Goldilocks’ landing won’t be a sure thing for the ASX
Rise and Shine: Everything you need to know before the ASX opens
ASX health stocks: Proteomics tumbles 22pc on delayed product launch, Race hits 10mth highs
